Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$10.27 – $18.67
53% from low
Exchange
OTC Link
OS
ONO PHARMACEUTICAL
No one on the platform currently holds OPHLF.
No tracked institution reports a position in OPHLF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $40.0000 | |
| 2026-09-30 | $40.0000 | |
| 2026-03-31 | $40.0000 | 2026-06-19 |
| 2025-09-30 | $40.0000 | 2025-12-01 |
| 2025-03-31 | $40.0000 | 2025-06-20 |
| 2024-09-30 | $40.0000 | 2024-12-02 |
| 2024-03-28 | $40.0000 | 2024-06-21 |
| 2023-09-29 | $40.0000 | 2023-12-01 |
No one on the platform has traded OPHLF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $465.9B | -8.5% | $155.76 | $150.04–$163.80 | 0.1× | 1 |
| 2028 | $456.7B | -2.0% | $139.65 | $134.53–$146.87 | 0.1× | 1 |
| 2029 | $469.6B | +2.8% | $146.48 | $141.10–$154.04 | 0.1× | 1 |
| 2030 | $498.9B | +6.2% | $159.68 | $153.81–$167.92 | 0.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $0.25 | $0.32 | +27.7% |
| 2026-05-08 | $0.05 | $0.01 | -80.8% |
| 2026-02-02 | $0.29 | $0.40 | +38.5% |
| 2025-10-30 | $0.27 | $0.32 | +16.4% |
| 2025-08-04 | $0.34 | $0.26 | -24.2% |
| 2025-05-08 | $0.09 | $-0.09 | -197.6% |
| 2025-02-03 | $0.27 | $0.21 | -21.1% |
| 2024-10-31 | $0.35 |
| $0.24 |
| -31.7% |
| +0.00% |
| $4.7B |
| — |
| HKMPYHikma Pharmaceuticals PLC | $45.35 | -1.86% | $4.7B | — |
| HLBBFH. Lundbeck A/S | $6.05 | +0.00% | $4.8B | — |
Source: Financial Modeling Prep · peers by sector/industry